William T. Melvin

6.2k total citations
94 papers, 5.2k citations indexed

About

William T. Melvin is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, William T. Melvin has authored 94 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pharmacology, 39 papers in Molecular Biology and 25 papers in Oncology. Recurrent topics in William T. Melvin's work include Pharmacogenetics and Drug Metabolism (41 papers), Glutathione Transferases and Polymorphisms (13 papers) and Drug Transport and Resistance Mechanisms (10 papers). William T. Melvin is often cited by papers focused on Pharmacogenetics and Drug Metabolism (41 papers), Glutathione Transferases and Polymorphisms (13 papers) and Drug Transport and Resistance Mechanisms (10 papers). William T. Melvin collaborates with scholars based in United Kingdom, United States and Germany. William T. Melvin's co-authors include Graeme I. Murray, M.D. Burke, Morag McFadyen, John E. Fothergill, Margaret E. Duncan, Judith McKay, William F. Greenlee, G I Murray, Richard Weaver and Patrick H. Rooney and has published in prestigious journals such as Nature, Nature Medicine and The Journal of Cell Biology.

In The Last Decade

William T. Melvin

92 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William T. Melvin United Kingdom 39 2.2k 1.7k 1.6k 1.5k 551 94 5.2k
Eliezer Huberman United States 55 5.9k 2.6× 1.6k 0.9× 806 0.5× 2.5k 1.7× 735 1.3× 153 9.3k
Unnur P. Thorgeirsson United States 38 3.4k 1.5× 2.3k 1.4× 607 0.4× 3.0k 2.0× 473 0.9× 83 7.5k
Peter Bannasch Germany 42 2.4k 1.1× 1.1k 0.7× 437 0.3× 1.6k 1.0× 528 1.0× 230 5.6k
Laurent Corcos France 37 2.0k 0.9× 951 0.6× 954 0.6× 559 0.4× 227 0.4× 105 4.8k
Nicoletta Ferrari Italy 36 2.0k 0.9× 785 0.5× 351 0.2× 737 0.5× 243 0.4× 113 3.7k
Daotai Nie United States 30 2.1k 1.0× 652 0.4× 299 0.2× 1.3k 0.8× 502 0.9× 63 3.8k
Sisko Anttila Finland 36 2.1k 1.0× 950 0.6× 691 0.4× 1.3k 0.8× 705 1.3× 91 4.6k
Stephen K. Durham United States 35 1.1k 0.5× 785 0.5× 519 0.3× 981 0.6× 231 0.4× 90 5.2k
Gary D. Kruh United States 49 3.0k 1.3× 4.3k 2.5× 431 0.3× 367 0.2× 431 0.8× 70 6.9k
Maria Eugenia Guicciardi United States 34 3.2k 1.4× 1.0k 0.6× 581 0.4× 748 0.5× 264 0.5× 61 7.1k

Countries citing papers authored by William T. Melvin

Since Specialization
Citations

This map shows the geographic impact of William T. Melvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William T. Melvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William T. Melvin more than expected).

Fields of papers citing papers by William T. Melvin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William T. Melvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William T. Melvin. The network helps show where William T. Melvin may publish in the future.

Co-authorship network of co-authors of William T. Melvin

This figure shows the co-authorship network connecting the top 25 collaborators of William T. Melvin. A scholar is included among the top collaborators of William T. Melvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William T. Melvin. William T. Melvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rentas, Francisco J., Lloyd H. Ketchum, William T. Melvin, et al.. (2005). Pathogen inactivation ofLeishmania donovani infantumin plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sanguinis. 90(2). 85–91. 89 indexed citations
2.
Carpenter, Brian, et al.. (2005). The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1765(2). 85–100. 191 indexed citations
3.
McFadyen, Morag, Margaret Cruickshank, I.D. Miller, et al.. (2001). Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer. British Journal of Cancer. 85(2). 242–246. 126 indexed citations
4.
McFadyen, Morag, et al.. (2001). Cytochrome P450 CYP1B1 protein expression:. Biochemical Pharmacology. 62(2). 207–212. 152 indexed citations
5.
McFadyen, Morag, et al.. (1999). Differential expression of CYP1A1, CYP1A2, CYP1B1 in human kidney tumours. Cancer Letters. 139(2). 199–205. 41 indexed citations
6.
Murray, Graeme I., M.E. Duncan, Erin Arbuckle, William T. Melvin, & John E. Fothergill. (1998). Matrix metalloproteinases and their inhibitors in gastric cancer. Gut. 43(6). 791–797. 142 indexed citations
7.
Labus, Marie, et al.. (1998). Expression of Wnt genes in early wound healing. Wound Repair and Regeneration. 6(1). 58–64. 48 indexed citations
8.
Murray, Graeme I., et al.. (1996). Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancer. Nature Medicine. 2(4). 461–462. 388 indexed citations
9.
Flannelly, Grainne, Gang Jiang, Deverick J. Anderson, et al.. (1995). Serial quantitation of HPV‐16 in the smears of women with mild and moderate dyskaryosis. Journal of Medical Virology. 47(1). 6–9. 18 indexed citations
10.
Duthie, Susan J., William T. Melvin, & M.D. Burke. (1994). Bromobenzene detoxification in the human liver-derived HepG2 cell line. Xenobiotica. 24(3). 265–279. 28 indexed citations
11.
Weaver, Richard, B. Dunbar, Maurice Dickins, et al.. (1994). Evidence for a new cytochrome P450 form induced by 3-methylcholanthrene in rats. Biochemical Pharmacology. 47(8). 1457–1460. 5 indexed citations
12.
McKay, Judith, Graeme I. Murray, Richard Weaver, et al.. (1993). Xenobiotic metabolising enzyme expression in colonic neoplasia.. Gut. 34(9). 1234–1239. 55 indexed citations
13.
Doostdar, Hamed, M.H. Grant, William T. Melvin, C. Roland Wolf, & M.D. Burke. (1993). The effects of inducing agents on cytochrome P450 and UDP-glucuronyltransferase activities in human HEPG2 hepatoma cells. Biochemical Pharmacology. 46(4). 629–635. 66 indexed citations
14.
Melvin, William T., et al.. (1993). Nucleotide sequence analysis of the serotype-specific epitope of infectious pancreatic necrosis virus. Archives of Virology. 129(1-4). 287–293. 31 indexed citations
15.
Murray, Graeme I., et al.. (1993). The expression of cytochrome P-450, epoxide hydrolase, and glutathione s-transferase in hepatocellular carcinoma. Cancer. 71(1). 36–43. 50 indexed citations
16.
Murray, Graeme I., et al.. (1993). Expression of xenobiotic metabolizing enzymes in breast cancer. The Journal of Pathology. 169(3). 347–353. 84 indexed citations
17.
Ouzounis, Christos & William T. Melvin. (1991). Primary and secondary structural patterns in eukaryotic cytochrome P‐450 families correspond to structures of the helix‐rich domain of Pseudomonas putida cytochrome P‐450cam. European Journal of Biochemistry. 198(2). 307–315. 20 indexed citations
18.
Doostdar, Hamed, Abraham Demoz, M.D. Burke, William T. Melvin, & M.H. Grant. (1990). Variation in drug-metabolizing enzyme activities during the growth of human Hep G2 hepatoma cells. Xenobiotica. 20(4). 435–441. 44 indexed citations
19.
Murray, Graeme I., Herb F. Sewell, S. W. B. Ewen, et al.. (1987). Cytochrome P-450 localization in normal human adult and foetal liver by immunocytochemistry using a monoclonal antibody against human cytochrome P—450. The Histochemical Journal. 19(10-11). 537–545. 21 indexed citations
20.
Melvin, William T., et al.. (1978). Excretion of spermidine from BHK-21/C13 cells exposed to 6-thioguanosine.. PubMed. 38(9). 3055–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eliezer Huberman Breakdown of academic impact, for papers by Unnur P. Thorgeirsson Breakdown of academic impact, for papers by Peter Bannasch Breakdown of academic impact, for papers by Laurent Corcos Breakdown of academic impact, for papers by Nicoletta Ferrari Breakdown of academic impact, for papers by Daotai Nie Breakdown of academic impact, for papers by Sisko Anttila Breakdown of academic impact, for papers by Stephen K. Durham Breakdown of academic impact, for papers by Gary D. Kruh Breakdown of academic impact, for papers by Maria Eugenia Guicciardi
Rankless by CCL
2026